M E OBrien
Overview
Explore the profile of M E OBrien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
657
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krenz J, OBrien M, Lee J, Hayes B
Am J Emerg Med
. 2020 May;
44:312-314.
PMID: 32354528
Purpose: Acute aortic dissection is a serious and life-threatening condition that requires prompt, effective management. The purpose of this study was to evaluate the efficacy and safety of esmolol for...
2.
McCarthy C, OCarroll O, OBrien M, McEnery T, Franciosi A, Gunaratnam C, et al.
Ir J Med Sci
. 2017 Aug;
187(2):429-434.
PMID: 28812224
Background: Candidaemia is an important nosocomial infection, seen frequently in immunocompromised and critically ill patients and increasingly recognised in cystic fibrosis (CF) patients with totally implantable venous access devices (TIVADs)....
3.
OBrien M, Murphy D, Plant B
Ir Med J
. 2014 Oct;
107(8):240-1.
PMID: 25282963
The diagnosis of Cystic Fibrosis (CF) requires a high clinical suspicion in patients presenting at all ages. Early recognition permits referral to a specialist centre and may reduce the morbidity...
4.
OBrien M
J Relig Health
. 2013 Dec;
21(1):68-80.
PMID: 24311355
This study examines religious faith as associated with adjustment to end-stage renal failure and its treatment regimen of maintenance hemodialysis. Both quantitative and qualitative data were collected initially and after...
5.
McSweeney F, OBrien M, Sheehan S, Plant B, Corcoran G
Ir Med J
. 2012 Nov;
105(8):275-7.
PMID: 23155916
There has been an increase in the number of pulmonary infections caused by non-tuberculous mycobacteria (NTM) in the non HIV-infected population with a heightened awareness clinically and in the laboratory...
6.
Romics Jr L, McNamara B, Cronin P, OBrien M, Relihan N, Redmond H
Ir J Med Sci
. 2008 Nov;
180(2):569-71.
PMID: 19005633
Introduction: Paraneoplastic neurological disorders are rare complications of breast carcinoma. Lambert-Eaton Myasthenic Syndrome (LEMS) is most commonly associated with small cell lung cancer. However, a combination of LEMS and subacute...
7.
de Boer R, Saini A, Johnston S, OBrien M, Ellis P, Verrill M, et al.
Breast
. 2004 Jan;
9(3):149-55.
PMID: 14731839
Despite the introduction of systemic chemotherapy, inflammatory breast cancer (IBC) remains a disease with a poor prognosis. We performed this phase II study to evaluate the efficacy of infusional chemotherapy...
8.
Kuhn E, Nie C, OBrien M, Withers R, Wintemute G, Hargarten S
Inj Prev
. 2002 Jul;
8(2):143-6.
PMID: 12120834
Objectives: To determine whether the firearms recovered in buyback programs in a large urban community are the types most closely associated with firearm fatalities in the same geographic area. Methods:...
9.
Gregory R, Smith I, Norton A, Ashley S, OBrien M
Clin Oncol (R Coll Radiol)
. 2002 Feb;
13(6):483-7.
PMID: 11824893
The majority of patients diagnosed with non-small cell lung carcinoma (NSCLC) present with advanced disease and, as such, are treated with palliative intent. Platinum-based combination chemotherapy plays an important role...
10.
Dowsett M, Bundred N, DeCensi A, Sainsbury R, Lu Y, Hills M, et al.
Cancer Epidemiol Biomarkers Prev
. 2001 Sep;
10(9):961-6.
PMID: 11535548
Purpose: Raloxifene is a selective estrogen receptor (ER) modulator approved for prevention and treatment of postmenopausal osteoporosis. This is an exploratory study of raloxifene in primary breast cancer patients. Experimental...